Literature DB >> 22261702

Genetic factors modulating the response to stimulant drugs in humans.

Amy B Hart, Harriet de Wit, Abraham A Palmer.   

Abstract

Individuals vary in their responses to stimulant drugs, and several lines of evidence suggest that the basis for this variation is at least partially genetic in origin. Association studies have examined the effects of polymorphisms in specific genes on acute and chronic responses to stimulant drugs. Several of these genetic polymorphisms are also associated with other psychiatric dimensions and disorders.This chapter examines the evidence for genetic associations between the genes that have been most carefully examined for their influence on the response to stimulant drugs.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22261702      PMCID： PMC3388157          DOI： 10.1007/7854_2011_187

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN： 1866-3370


  164 in total

1.  Age differences in short-term retention of rapidly changing information.

Authors:  W K KIRCHNER
Journal:  J Exp Psychol       Date:  1958-04

Review 2.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

3.  Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.

Authors:  Mark A Bellgrove; Ziarih Hawi; Aiveen Kirley; Michael Fitzgerald; Michael Gill; Ian H Robertson
Journal:  Neuropsychopharmacology       Date:  2005-12       Impact factor: 7.853

4.  Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.

Authors:  Luis A Rohde; Tatiana Roman; Claudia Szobot; Renato D Cunha; Mara H Hutz; Joseph Biederman
Journal:  Synapse       Date:  2003-05       Impact factor: 2.562

5.  Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.

Authors:  Hiroshi Ujike; Takeshi Katsu; Yuko Okahisa; Manabu Takaki; Masafumi Kodama; Toshiya Inada; Naohisa Uchimura; Mitsuhiko Yamada; Nakao Iwata; Ichiro Sora; Masaomi Iyo; Norio Ozaki; Shigetoshi Kuroda
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-03-10       Impact factor: 5.067

6.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.

Authors:  Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; David W Oslin; Charles A Dackis; Charles P O'Brien; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

8.  Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes.

Authors:  Britta Haenisch; Karoline Linsel; Michael Brüss; Ralf Gilsbach; Peter Propping; Markus M Nöthen; Marcella Rietschel; Rolf Fimmers; Wolfgang Maier; Astrid Zobel; Susanne Höfels; Vera Guttenthaler; Manfred Göthert; Heinz Bönisch
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-10-05       Impact factor: 3.568

9.  Genome-wide association for methamphetamine dependence: convergent results from 2 samples.

Authors:  George R Uhl; Tomas Drgon; Qing-Rong Liu; Catherine Johnson; Donna Walther; Tokutaro Komiyama; Mutsuo Harano; Yoshimoto Sekine; Toshiya Inada; Norio Ozaki; Masaomi Iyo; Nakao Iwata; Mitsuhiko Yamada; Ichiro Sora; Chih-Ken Chen; Hsing-Cheng Liu; Hiroshi Ujike; Shih-Ku Lin
Journal:  Arch Gen Psychiatry       Date:  2008-03

10.  Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.

Authors:  Jiajun Shi; Elliot S Gershon; Chunyu Liu
Journal:  Schizophr Res       Date:  2008-08-20       Impact factor: 4.939
View more
  12 in total

1.  Personality and the acute subjective effects of d-amphetamine in humans.

Authors:  Matthew G Kirkpatrick; Chris-Ellyn Johanson; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2013-01-23       Impact factor: 4.153

2.  Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults.

Authors:  Adam M Leventhal; Matthew G Kirkpatrick; Mollie S Pester; John E McGeary; Robert M Swift; Steve Sussman; Christopher W Kahler
Journal:  Psychopharmacology (Berl)       Date:  2016-10-22       Impact factor: 4.530

3.  Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis.

Authors:  C D Bryant; L A Kole; M A Guido; G Sokoloff; A A Palmer
Journal:  Genes Brain Behav       Date:  2012-05-02       Impact factor: 3.449

4.  A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.

Authors:  C J Spellicy; M J Harding; S C Hamon; J J Mahoney; J A Reyes; T R Kosten; T F Newton; R De La Garza; D A Nielsen
Journal:  Genes Brain Behav       Date:  2014-03-17       Impact factor: 3.449

5.  Psychopharmacology of theobromine in healthy volunteers.

Authors:  Matthew J Baggott; Emma Childs; Amy B Hart; Eveline de Bruin; Abraham A Palmer; Joy E Wilkinson; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2013-02-19       Impact factor: 4.530

6.  Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.

Authors:  Christopher T Smith; Jessica Weafer; Ronald L Cowan; Robert M Kessler; Abraham A Palmer; Harriet de Wit; David H Zald
Journal:  J Psychopharmacol       Date:  2016-02-15       Impact factor: 4.153

7.  Effects of familial risk and stimulant drug use on the anticipation of monetary reward: an fMRI study.

Authors:  Alanna L Just; Chun Meng; Dana G Smith; Edward T Bullmore; Trevor W Robbins; Karen D Ersche
Journal:  Transl Psychiatry       Date:  2019-02-04       Impact factor: 6.222

8.  Functional Genomic Analysis of Amphetamine Sensitivity in Drosophila.

Authors:  Caline S Karam; Brenna L Williams; Irina Morozova; Qiaoping Yuan; Rony Panarsky; Yuchao Zhang; Colin A Hodgkinson; David Goldman; Sergey Kalachikov; Jonathan A Javitch
Journal:  Front Psychiatry       Date:  2022-02-18       Impact factor: 5.435

9.  Genome-wide association study of stimulant dependence.

Authors:  Jiayi Cox; Richard Sherva; Leah Wetherill; Tatiana Foroud; Howard J Edenberg; Henry R Kranzler; Joel Gelernter; Lindsay A Farrer
Journal:  Transl Psychiatry       Date:  2021-06-29       Impact factor: 6.222

10.  Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F45/F46 advanced intercross line.

Authors:  Camron D Bryant; Loren A Kole; Michael A Guido; Riyan Cheng; Abraham A Palmer
Journal:  Front Genet       Date:  2012-07-11       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.